These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 3590711

  • 1. [Immunosuppressors and immunostimulants in the treatment of chronic glomerulonephritis patients with the nephrotic syndrome].
    Nazar PS.
    Vrach Delo; 1987 Mar; (3):86-9. PubMed ID: 3590711
    [No Abstract] [Full Text] [Related]

  • 2. [Immunogenesis and hemostasis in patients with exacerbated chronic glomerulonephritis treated with thymalin].
    Budazhabon GV, Kuznik BI, Morozov VG, Orlova NN, Khavinson VKh.
    Ter Arkh; 1984 Mar; 56(10):62-6. PubMed ID: 6549229
    [No Abstract] [Full Text] [Related]

  • 3. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
    Krasnova TN, Tareeva IE, Shilov EM, Mukhin NA, Miroshnichenko NG.
    Ter Arkh; 1997 Mar; 69(6):21-3. PubMed ID: 9297266
    [Abstract] [Full Text] [Related]

  • 4. [The treatment of nephrotic-type chronic glomerulonephritis with Sandimmun (cyclosporin A)].
    Mukhin NA, Tareeva IE, Krasnova TN, Shilov EM, Miroshnichenko NG.
    Ter Arkh; 1995 Mar; 67(8):13-5. PubMed ID: 7482320
    [Abstract] [Full Text] [Related]

  • 5. [The efficacy of combined therapy with immunodepressants, anticoagulants and antiaggregants in certain clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa, Biriukova LS, Makurov AI.
    Ter Arkh; 1992 Mar; 64(8):47-50. PubMed ID: 1440396
    [No Abstract] [Full Text] [Related]

  • 6. [The cyclophosphamide treatment of glomerulonephritis patients].
    Dorets'kyĭ VV.
    Vrach Delo; 1991 Feb; (2):51-3. PubMed ID: 2058123
    [Abstract] [Full Text] [Related]

  • 7. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL, Shkerina LI, Shilov EM.
    Klin Med (Mosk); 2005 Feb; 83(10):48-50. PubMed ID: 16320847
    [Abstract] [Full Text] [Related]

  • 8. [The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane].
    Krasnova TN, Shilov EM, Ivanov AA, Samoĭlov DV, Gordovskaia NB, Miroshnichenko NG, Tareeva IE.
    Ter Arkh; 1991 Feb; 63(6):115-8. PubMed ID: 1948725
    [Abstract] [Full Text] [Related]

  • 9. [Immunosuppressive therapy update 2010 for ANCA-associated glomerulonephritis and intractable nephrotic syndrome].
    Yoshida M.
    Nihon Jinzo Gakkai Shi; 2010 Feb; 52(1):1-9. PubMed ID: 20166533
    [No Abstract] [Full Text] [Related]

  • 10. [The immunodeficiency state and the efficacy of the glucocorticoid therapy of patients with glomerulonephritis and the nephrotic syndrome].
    Kolesnyk MO, Dorets'kyĭ VV.
    Lik Sprava; 1992 Feb; (11-12):53-5. PubMed ID: 1292222
    [Abstract] [Full Text] [Related]

  • 11. [The pharmacotherapy of chronic glomerulonephritis].
    Ratner MIa, Biriukova LS.
    Klin Med (Mosk); 1992 Jan; 70(1):114-9. PubMed ID: 1608196
    [No Abstract] [Full Text] [Related]

  • 12. [Therapeutic effect of cyclophosphamide in patients with chronic glomerulonephritis with nephrotic syndrome].
    Duman VL.
    Ter Arkh; 2002 Jan; 74(6):39-41. PubMed ID: 12136481
    [Abstract] [Full Text] [Related]

  • 13. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
    Ponticelli C, Brancaccio D, Locatelli F, Imbasciati E.
    Minerva Nefrol; 1969 Jan; 16(3):228-34. PubMed ID: 5356052
    [No Abstract] [Full Text] [Related]

  • 14. [Immunosuppressive treatment of chronic glomerulonephritis, nephrotic syndrome, ulcerative colitis, Crohn's disease and chronic active hepatitis].
    Britton M.
    Lakartidningen; 1976 Apr 21; 73(17):1634-6, 1638-9. PubMed ID: 1263688
    [No Abstract] [Full Text] [Related]

  • 15. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN, Shilov EM, Tareeva IE, Gordovskaia NB, Lavrova ON, Miroshnichenko NG, Troepol'skaia OV, Ivanova LV, Ivanov AA.
    Ter Arkh; 1998 Apr 21; 70(6):14-7. PubMed ID: 9695216
    [Abstract] [Full Text] [Related]

  • 16. Immunosuppressive therapy.
    Winkelstein A, Segel D, Stolzer BL, Fogel M, Shadduck RK, Lewis M.
    Am J Med Sci; 1973 Feb 21; 265(2):92-108. PubMed ID: 4736193
    [No Abstract] [Full Text] [Related]

  • 17. [Immunologic problems of glomerulonephritis].
    Dutz H, Philipp H.
    Z Arztl Fortbild (Jena); 1971 Jun 01; 65(11):554-60. PubMed ID: 5570284
    [No Abstract] [Full Text] [Related]

  • 18. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa, Fedorova ND.
    Urol Nefrol (Mosk); 1996 Jun 01; (2):32-5. PubMed ID: 8677550
    [Abstract] [Full Text] [Related]

  • 19. [Steroid and immunosuppressive therapy in primary glomerular nephropathy (glomerulonephritis) in adults. Clinical and nephrobioptic study].
    Bonomini V, Mioli V, Albertazzi A, Vangelista A.
    Minerva Nefrol; 1969 Jun 01; 16(2):103-19. PubMed ID: 5398499
    [No Abstract] [Full Text] [Related]

  • 20. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A, Chongchate N, Suntornpoch V, Pattaragarn A, Supavekin S.
    J Med Assoc Thai; 2005 Nov 01; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.